FDA Hold On Geron’s Stem Cell Trial

Animals being tested using Geron Corporation’s treatment for spinal cord injury developed cysts at the injury sites, a finding that led the U.S. FDA to place a clinical hold on a planned human trial of the treatment. The treatment in question involved embryonic stem cells. Stem Cell Research News